BridgeBio Pharma Inc (BBIO) stock is up 207.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BBIO stock a score of 68 out of a possible 100.
That rank is influenced by a short-term technical score of 75. BBIO's rank also includes a long-term technical score of 68.
BBIO has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on BBIO!
BridgeBio Pharma Inc (BBIO) stock has gained 1.11% while the S&P 500 is lower by -0.26% as of 12:30 PM on Thursday, Nov 30. BBIO is up $0.32 from the previous closing price of $28.47 on volume of 414,434 shares. Over the past year the S&P 500 has risen 11.24% while BBIO is up 207.26%. BBIO lost -$3.91 per share in the over the last 12 months.
Click Here to get the full Stock Report for BridgeBio Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
